NatalizumabHypersensitivity managed with desensitisation: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2010年 / 1286卷 / 1期

关键词：

Public Health; Multiple Sclerosis; Negative Control; Interferon; Patient Outcome;

D O I：

10.2165/00128415-201012860-00076

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：24 / 24

相关论文

共 50 条

[1] NatalizumabHypersensitivity, with subsequent desensitisation: case report
Reactions Weekly, 2013, 1459 (1) : 28 - 28
[2] NatalizumabHypersensitivity, with subsequent desensitisation: case report
Reactions Weekly, 2012, 1394 (1) : 32 - 32
[3] NatalizumabHypersensitivity, with subsequent desensitisation: case report
Reactions Weekly, 2012, 1402 (1) : 34 - 34
[4] FurosemideHypersensitivity managed by desensitisation: case report
Reactions Weekly, 2010, 1294 (1) : 20 - 20
[5] CeftriaxoneAnaphylaxis managed by desensitisation: case report
Reactions Weekly, 2009, 1265 (1) : 13 - 13
[6] OmalizumabHypersensitivity managed with desensitisation: case report
Reactions Weekly, 2014, 1489 (1) : 28 - 28
[7] AlemtuzumabHypersensitivity managed with desensitisation: case report
Reactions Weekly, 2014, 1489 (1) : 6 - 6
[8] InsulinsAllergy, managed with desensitisation: case report
Reactions Weekly, 2014, 1517 (1) : 113 - 113
[9] DoxycyclineAnaphylaxis, managed with desensitisation: case report
Reactions Weekly, 2013, 1467 (1) : 16 - 16
[10] CisplatinHypersensitivity reaction, managed with desensitisation: case report
Reactions Weekly, 2014, 1520 (1) : 67 - 67

← 1 2 3 4 5 →